Search Results - "CARIGNOLA, R."

Patients with antiphosholipid syndrome and thrombotic recurrences: A real world observation (the Piedmont cohort study) by Bazzan, M, Vaccarino, A, Stella, S, Sciascia, S, Montaruli, B, Bertero, M T, Carignola, R, Roccatello, D

“…Patients with antiphospholipid syndrome (APS) often have thrombotic recurrences, sometimes despite appropriate ongoing anticoagulant treatment. Identifying APS…”
Get full text

Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): demographic features, risk factors, clinical and laboratory profile by Bertero, MT, Bazzan, M, Carignola, R, Montaruli, B, Silvestro, E, Sciascia, S, Vaccarino, A, Baldovino, S, Roccatello, D

“…We report the experience from the Antiphospholipid Antibodies (aPL) Regional Consortium in northwest Italy, meant to support clinical research and foster…”
Get full text

Anti-cardiolipin and anti-β2-glycoprotein I antibodies: normal reference ranges in northwestern Italy by Montaruli, B, De Luna, E, Mengozzi, G, Molinari, F, Napolitano, E, Napoli, P, Nicolo, C, Romito, A, Stella, S, Bazzan, M, Bertero, MT, Carignola, R, Marchese, C

“…Laboratory tests for anticardiolipin antibodies (aCL) and anti-β2glycoprotein I antibodies (a-β2GPI) face problems common to many autoantibody assays: the lack…”
Get full text

Anti-cardiolipin and anti- beta 2-glycoprotein I antibodies: normal reference ranges in northwestern Italy by Montaruli, B, De Luna, E, Mengozzi, G, Molinari, F, Napolitano, E, Napoli, P, Nicolo, C, Romito, A, Stella, S, Bazzan, M, Bertero, M T, Carignola, R, Marchese, C

“…Laboratory tests for anticardiolipin antibodies (aCL) and anti- beta 2glycoprotein I antibodies (a- beta 2GPI) face problems common to many autoantibody…”
Get full text

Effects of intermediate doses of glucocorticoids on bone turnover and circulating Dkk-1, MIF, sRANKL and OPG in patients with interstitial lung disease. A three-month longitudinal study by Calzolari, G, Dovio, A, Palmas, E, Data, V, Carignola, R, Mercante, L, Albera, C, Angeli, A

Get full text

Etiopathogenetic mechanisms of fibromyalgia syndrome by Stisi, S, Cazzola, M, Buskila, D, Spath, M, Giamberardino, M A, Sarzi-Puttini, P, Arioli, G, Alciati, A, Leardini, G, Gorla, R, Marsico, A, Ceccherelli, F, Bazzichi, L, Carignola, R, Gracely, R H, Salaffi, F, Marinangeli, F, Torta, R, Di Franco, M, Biasi, G, Cassisi, G, Casale, R, Altomonte, L, Atzeni, F

“…Fibromyalgia syndrome (FMS) is a common chronic condition of widespread pain with causal mechanisms that are largely unknown. It is characterized by moderate…”
Get full text

Symptoms and signs in fibromyalgia syndrome by Cassisi, G, Sarzi-Puttini, P, Alciati, A, Casale, R, Bazzichi, L, Carignola, R, Gracely, R H, Salaffi, F, Marinangeli, F, Torta, R, Giamberardino, M A, Buskila, D, Spath, M, Cazzola, M, Di Franco, M, Biasi, G, Stisi, S, Altomonte, L, Arioli, G, Leardini, G, Gorla, R, Marsico, A, Ceccherelli, F, Atzeni, F

“…Fibromyalgia syndrome (FM) is a common chronic pain condition that affects at least 2% of the adult population. Chronic widespread pain is the defining feature…”
Get full text

Fibromyalgia syndrome: the pharmacological treatment options by Sarzi-Puttini, P, Torta, R, Marinangeli, F, Biasi, G, Spath, M, Buskila, D, Gracely, R H, Giamberardino, M A, Bazzichi, L, Cazzola, M, Di Franco, M, Stisi, S, Salaffi, F, Casale, R, Leardini, G, Gorla, R, Marsico, A, Carignola, R, Altomonte, L, Ceccherelli, F, Cassisi, G, Arioli, G, Alciati, A, Atzeni, F

“…Pharmacological treatment has been gradually enriched by a variety of compounds; however, no single drug is capable of fully managing the constellation of…”
Get full text

Non pharmacological treatments in fibromyalgia by Casale, R, Cazzola, M, Arioli, G, Gracely, R H, Ceccherelli, F, Atzeni, F, Stisi, S, Cassisi, G, Altomonte, L, Alciati, A, Leardini, G, Gorla, R, Marsico, A, Torta, R, Giamberardino, M A, Buskila, D, Spath, M, Marinangeli, F, Bazzichi, L, Di Franco, M, Biasi, G, Salaffi, F, Carignola, R, Sarzi-Puttini, P

“…Fibromyalgia is a complex syndrome associated with significant impairment in quality of life and function and with substantial financial costs. Once the…”
Get full text

Fibromyalgia syndrome: definition and diagnostic aspects by Cazzola, M, Sarzi Puttini, P, Stisi, S, Di Franco, M, Bazzichi, L, Carignola, R, Gracely, R H, Salaffi, F, Marinangeli, F, Torta, R, Giamberardino, M A, Buskila, D, Spath, M, Biasi, G, Cassisi, G, Casale, R, Altomonte, L, Arioli, G, Alciati, A, Marsico, A, Ceccherelli, F, Leardini, G, Gorla, R, Atzeni, F

“…Ever since it was first defined, fibromyalgia (FM) has been considered one of the most controversial diagnoses in the field of rheumatology, to the point that…”
Get full text

The evaluation of the fibromyalgia patients by Atzeni, F, Salaffi, F, Bazzichi, L, Gracely, R H, Carignola, R, Torta, R, Gorla, R, Marsico, A, Ceccherelli, F, Cazzola, M, Buskila, D, Spath, M, Di Franco, M, Biasi, G, Cassisi, G, Stisi, S, Casale, R, Altomonte, L, Arioli, G, Alciati, A, Leardini, G, Marinangeli, F, Giamberardino, M A, Sarzi-Puttini, P

“…Fibromyalgia (FM) is a rheumatic disease characterized by musculoskeletal pain, chronic diffuse tension and/or stiffness in joints and muscles, easy fatigue,…”
Get full text

Fibromyalgia syndrome: preventive, social and economic aspects by Altomonte, L, Atzeni, F, Leardini, G, Marsico, A, Gorla, R, Casale, R, Cassisi, G, Stisi, S, Salaffi, F, Marinangeli, F, Giamberardino, M A, Di Franco, M, Biasi, G, Arioli, G, Alciati, A, Ceccherelli, F, Bazzichi, L, Carignola, R, Cazzola, M, Torta, R, Buskila, D, Spath, M, Gracely, R H, Sarzi-Puttini, P

“…There many open questions concerning the concept of primary prevention in FM. Diagnostic or classification criteria are not universally accepted, and this…”
Get full text

CLINICAL CHALLENGE: AORTITIS IN THE EMERGENCY DEPARTMENT by Renon, F, Depaoli, A, Quaglia, P, Carignola, R, Cingolani, M, Suppo, U, Cannillo, M, Grosso Marra, W

“…A 67 yo woman presented to the ED for a sustained episode of palpitations and acute chest pain. Past medical history: suspected psoriatic arthritis previously…”
Get full text

Circadian Abnormalities of Natural Killer Cell Activity in Rheumatoid Arthritis by MASERA, R. G., CARIGNOLA, R., SARTORI, M. L., STAURENGHI, A. H., ANGELI, A.

Get full text

Thrombotic recurrences and bleeding events in APS vascular patients: A review from the literature and a comparison with the APS Piedmont Cohort by Bazzan, M, Vaccarino, A, Stella, S, Bertero, M.T, Carignola, R, Montaruli, B, Roccatello, D, Shoenfeld, Y

“…Abstract In APS vascular patients, thrombotic recurrences are more frequent than in non-APS thrombotic patients. To better define this clinical setting, a…”
Get full text

Psychoemotional, cognitive, chronoendocrine, and immune responses to a survival performance in an African desert. Evidence for divergent effects by Gatti, G, Meluzzi, A, Francesetti, G, Masera, R, Sartori, M L, Maina, L, Carignola, R, Angeli, A

Get more information

Anti-cardiolipin and anti-[Beta]2-glycoprotein I antibodies: normal reference ranges in northwestern Italy by Montaruli, B, De Luna, E, Mengozzi, G, Molinari, F, Napolitano, E, Napoli, P, Nicolo, C, Romito, A, Stella, S, Bazzan, M, Bertero, MT, Carignola, R, Marchese, C

“…Laboratory tests for anticardiolipin antibodies (aCL) and anti-β2glycoprotein I antibodies (a-β2GPI) face problems common to many autoantibody assays: the lack…”
Get full text

In vitro effects of β-endorphin and cortisol on human natural killer (NK) cell activity by MASERA, R, GATTI, G, SARTORI, M. L, CARIGNOLA, R, MAGRO, E, ANGELI, A

Get full text

Altered circadian rhythms of natural killer (NK) cell activity in patients with autoimmune rheumatic diseases by Masera, R G, Carignola, R, Staurenghi, A H, Sartori, M L, Lazzero, A, Griot, G, Angeli, A

“…Natural Killer (NK) cells are a lymphocyte subset actively involved in cytotoxicity against tumor-transformed and virus-infected cells; they are a reliable…”
Get more information

Chronobiological aspects of neuroendocrine-immune interactions by Angeli, A, Gatti, G, Masera, R, Sartori, M L, Carignola, R

Get more information